171 related articles for article (PubMed ID: 28931725)
21. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
22. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
[TBL] [Abstract][Full Text] [Related]
23. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
24. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
25. YAP contributes to DNA methylation remodeling upon mouse embryonic stem cell differentiation.
Passaro F; De Martino I; Zambelli F; Di Benedetto G; Barbato M; D'Erchia AM; Manzari C; Pesole G; Mutarelli M; Cacchiarelli D; Antonini D; Parisi S; Russo T
J Biol Chem; 2021; 296():100138. PubMed ID: 33268382
[TBL] [Abstract][Full Text] [Related]
26. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
27. Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells.
Yang CS; Stampouloglou E; Kingston NM; Zhang L; Monti S; Varelas X
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29661856
[TBL] [Abstract][Full Text] [Related]
28. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
29. YAP and TAZ, the conductors that orchestrate eye development, homeostasis, and disease.
Zhu JY; Lin S; Ye J
J Cell Physiol; 2018 Jan; 234(1):246-258. PubMed ID: 30094836
[TBL] [Abstract][Full Text] [Related]
30. VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.
Zhang Y; Shen H; Withers HG; Yang N; Denson KE; Mussell AL; Truskinovsky A; Fan Q; Gelman IH; Frangou C; Zhang J
Sci Rep; 2017 Jul; 7(1):6190. PubMed ID: 28733631
[TBL] [Abstract][Full Text] [Related]
31. IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways.
Hou L; Xie S; Li G; Xiong B; Gao Y; Zhao X; Hu J; Deng S; Jiang J
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):549-557. PubMed ID: 29781562
[TBL] [Abstract][Full Text] [Related]
32. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy.
Hou N; Wen Y; Yuan X; Xu H; Wang X; Li F; Ye B
Exp Mol Pathol; 2017 Dec; 103(3):267-275. PubMed ID: 29154888
[TBL] [Abstract][Full Text] [Related]
33. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
[TBL] [Abstract][Full Text] [Related]
34. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R
Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233
[TBL] [Abstract][Full Text] [Related]
35. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
36. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.
Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G
J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433
[TBL] [Abstract][Full Text] [Related]
37. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
39. YAP and TAZ are essential for basal and squamous cell carcinoma initiation.
Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149
[TBL] [Abstract][Full Text] [Related]
40. The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling.
Hillmer RE; Link BA
Cells; 2019 May; 8(5):. PubMed ID: 31137701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]